In a nationwide study, one fifth of surgeons had high AVG use rates, exceeding the guidelines threshold of 34%. The Centers for Medicare and Medicaid established an arteriovenous fistula (AVF) ...

Rates of arteriovenous fistula (AVF) placement in patients approaching hemodialysis in the United States are significantly lower in metropolitan than micropolitan areas, researchers reported online ...

August 6, 2010 — Patients with end-stage renal disease (ESRD) who live in poorer parts of the United States are less likely to receive an arteriovenous fistula (AVF) for hemodialysis vascular access ...

Please provide your email address to receive an email when new articles are posted on . The type of arteriovenous access placement, graft or fistula, used first in older patients receiving ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Placement of an arteriovenous fistula in patients with chronic kidney disease not on dialysis can ...

Owing to the overall poor medical health of patients with end-stage renal disease, we have sought alternatives to the use of general anesthesia for access procedures. Furthermore, since local ...

Early arteriovenous fistula (AVF) creation is generally considered to be the best strategy when planning a vascular access for haemodialysis (HD). However, new data suggest that very early AVF ...

Kidney disease patients insured by some federally sponsored national health care organizations are more likely to undergo an important predialysis procedure than patients with other types of insurance ...

Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings ...

WALTHAM, Mass., Jan. 4, 2013 /PRNewswire/ -- Proteon Therapeutics, Inc., a private biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of ...